Bing Hua

541 citations
16 papers · 265 indexed · h-index 9
Topics
Cardiovascular Function and Risk Factors (6 papers)Advanced Glycation End Products research (5 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Bing Hua

13 papers receiving 260 citations

Peers

Bing Hua
Comparison fields: 5 of 55
  • Cardiology and Cardiovascular Medicine 151
  • Endocrinology, Diabetes and Metabolism 134
  • Epidemiology 60
  • Radiology, Nuclear Medicine and Imaging 46
  • Surgery 44
Replace Libin Ren with:
Libin Ren China
Xunxun Feng China
Yuecheng Hu China
Raphael See United States
Gideon Valstar Netherlands
Zhenyu Liu China
Vincenzo Pernice Italy
Motoji Naka Japan
Bing Hua relative to Libin Ren China Libin Ren's profile →
Citations per field
00.5×4.5×
Libin Ren · 1×
Citations per year

Countries citing papers authored by Bing Hua

Since Specialization
Citations

This map shows the geographic impact of Bing Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Hua more than expected).

Fields of papers citing papers by Bing Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Hua. The network helps show where Bing Hua may publish in the future.

Co-authorship network of co-authors of Bing Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Hua. A scholar is included among the top collaborators of Bing Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Hua. Bing Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 4
2 0
3 4
4 9
5 64
6 42
7 73
8 1
9 11
10 9
11 0
12 15
13 12
14 15
15 6
16 0

About Bing Hua

Bing Hua is a scholar working on Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 16 papers that have together received 265 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (6 papers), Advanced Glycation End Products research (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (134 citations), Cardiology and Cardiovascular Medicine (151 citations) and Radiology, Nuclear Medicine and Imaging (46 citations). Bing Hua has collaborated with scholars based in China and United States. Frequent co-authors include Hongwei Li, Weiping Li, Qingbo Liu, Xiaosong Ding, Hui Gao, Hui Chen, Xue‐Qiao Zhao, Yue Zhang, Yue Zhang and Xue-Qiao Zhao. Their work appears in journals such as Journal of the American College of Cardiology, Medicine and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026